Straumann, CH1175448666

Goldman adds Straumann to picks and sets CHF 125 target for Straumann stock

Published on 10/06/2026 at 10:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Goldman sets a CHF 125 target on October 2, 2026, citing China. Straumann stock costs EUR 98.75 on October 6, 2026 after EUR 98.42, plus 0.34 percent.

Reinraum-Fertigung von Dentalimplantaten mit Ingenieuren an Präzisionsmaschinen
Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann will enter Goldman Sachs' October conviction list with a CHF 125 price target, according to CNBC on October 2, 2026. The bank cited improving sales growth and business conditions in China, while also flagging softer U.S. dental-procedure demand and uncertainty around Chinese price reforms.

Goldman targets China recovery

The CHF 125 target gives the analyst view a concrete valuation anchor for the Swiss dental-implant maker. Goldman analyst Richard Felton also expects losses in Straumann's orthodontics business to narrow, linking the target to both regional demand and operating improvement.

The latest market context is the scheduled third-quarter report. MarketScreener reported on October 5, 2026 that Straumann will publish third-quarter 2026 results on October 28, 2026, at approximately 7:00 a.m. CET.

Revenue growth meets margin expansion

Straumann's first-half 2026 revenue reached CHF 1,379.5 million, up 7.8 percent organically, according to Investing.com in its results summary dated August 19, 2026. Core EBIT was CHF 354.8 million and the core EBIT margin reached 26.9 percent at constant 2025 exchange rates.

Management confirmed full-year 2026 guidance for high-single-digit organic revenue growth and 140 to 170 basis points of core EBIT margin expansion at constant 2025 exchange rates. That combination matters because Straumann is being valued on both demand recovery and improved profitability, rather than on revenue growth alone.

Results date sets the next test

Straumann is listed on the SIX Swiss Exchange under ticker STMN. The finance quote showed a market capitalization of CHF 14.7 billion on October 6, 2026, while the 52-week range cited by Investing.com extended from CHF 73.02 to CHF 109.80 on October 5, 2026.

Straumann stock was trading at EUR 98.75 at Lang & Schwarz on October 6, 2026 at 10:09 a.m. CEST, plus 0.34 percent versus the prior close of EUR 98.42. The further course of trading is shown by the continuously updated real-time quote of Straumann stock.

Straumann stock facts

  • Company: Straumann Holding AG
  • ISIN: CH1175448666
  • Ticker: STMN
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz (as of October 6, 2026, 10:09 a.m. CEST): EUR 98.75
  • Change versus prior close: plus 0.34 percent
  • Prior close Lang & Schwarz (October 5, 2026): EUR 98.42
  • Market capitalization: CHF 14.7 billion (as of October 6, 2026)
  • 52-week range: CHF 73.02-109.80 (as of October 5, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies
  • Next earnings date: October 28, 2026

More news and analysis on Straumann stock

Disclaimer...

en | CH1175448666 | STRAUMANN | boerse | 70240378 | bgmi